Screener
Relay Therapeutics, Inc. RLAY Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Relay Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Relay Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338056
FAQ
- What is Relay Therapeutics, Inc.'s debt-to-equity?
- Relay Therapeutics, Inc. (RLAY) reported debt-to-equity of 0× in Q2 2026.
- How has Relay Therapeutics, Inc.'s debt-to-equity changed year-over-year?
- Relay Therapeutics, Inc.'s debt-to-equity decreased by 33.1% year-over-year, from 0.1× to 0×.
- What is the long-term trend for Relay Therapeutics, Inc.'s debt-to-equity?
- Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s debt-to-equity has grown at a 12.3% compound annual growth rate (CAGR), from 0× to 0.1×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Relay Therapeutics, Inc.'s debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude